Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer
- 31 July 2010
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 121 (1-2), 403-407
- https://doi.org/10.1016/j.jsbmb.2010.03.009
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Deguelin Inhibits Growth of Breast Cancer Cells by Modulating the Expression of Key Members of the Wnt Signaling PathwayCancer Prevention Research, 2009
- Chronic inflammation and oxidative stress in human carcinogenesisInternational Journal of Cancer, 2007
- CYP27A1 and CYP24 Expression as a Function of Malignant Transformation in the ColonJournal of Histochemistry & Cytochemistry, 2007
- Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel diseaseProgress in Biophysics and Molecular Biology, 2006
- Chemoprevention of Prostate Cancer by Cholecalciferol (Vitamin D3): 25-hydroxylase (CYP27A1) in Human Prostate Epithelial CellsClinical & Experimental Metastasis, 2005
- A Novel RARβ Isoform Directed by a Distinct Promoter P3 and Mediated by Retinoic Acid in Breast Cancer CellsCancer Research, 2004
- A Crucial Role for the Vitamin D Receptor in Experimental Inflammatory Bowel DiseasesMolecular Endocrinology, 2003
- Vitamin D Status, Parathyroid Hormone and Bone Mineral Density in Patients with Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 2002
- 1,25-Dihydroxycholecalciferol Prevents and Ameliorates Symptoms of Experimental Murine Inflammatory Bowel DiseaseJournal of Nutrition, 2000
- Improved Cholecalciferol Nutrition in Rats Is Noncalcemic, Suppresses Parathyroid Hormone and Increases Responsiveness to 1,25-DihydroxycholecalciferolJournal of Nutrition, 2000